Pharmelle

Pharmelle is a specialty pharmaceutical company dedicated to women's health, with a specific focus on prenatal nutrition and prescription supplementation. The company provides advanced nutritional solutions designed to support women during preconception, pregnancy, and postnatal periods. Pharmelle's product portfolio includes well-known brands such as Prena1 and NeevoDHA, which utilize high-quality ingredients like Quatrefolic to ensure optimal absorption. In 2014, the company was acquired by Exeltis, a global leader in women's healthcare and a division of Insud Pharma. Following the acquisition, Pharmelle's operations and products were integrated into Exeltis USA, where they continue to be a staple in the obstetric market.